Hexoskin @ LSI USA 2026

February 12, 2026

Fresh off FDA clearance, Hexoskin will be in Dana Point this March at the annual LSI USA conference where we’ll be discussing our expansion plans with partners and investors.

We'll also present new developments about our AI models for clinical trials and remote diagnostics, and our digital biomarker pipeline in cardiology, respiratory diseases, nervous system disorders, and rare diseases.

Contact us if you're attending: contact@hexoskin.com